3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclobutyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclohexyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclopentyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-(2-methylpropyl)-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-prop-2-enyl-3,4-dihydro-2H-chromene-6-carboxamide

C159H156N32O12 — CID 160602306

IUPAC3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclobutyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclohexyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclopentyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-(2-methylpropyl)-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-prop-2-enyl-3,4-dihydro-2H-chromene-6-carboxamide
SMILESC=CCNC(=O)c1ccc2c(c1)CC(C1=Nc3cc(-c4ccnc(N)n4)ccc3C1)CO2.CC(C)CNC(=O)c1ccc2c(c1)CC(C1=Nc3cc(-c4ccnc(N)n4)ccc3C1)CO2.Nc1nccc(-c2ccc3c(c2)N=C(C2COc4ccc(C(=O)NC5CCC5)cc4C2)C3)n1.Nc1nccc(-c2ccc3c(c2)N=C(C2COc4ccc(C(=O)NC5CCCC5)cc4C2)C3)n1.Nc1nccc(-c2ccc3c(c2)N=C(C2COc4ccc(C(=O)NC5CCCCC5)cc4C2)C3)n1.Nc1nccc(-c2ccc3c(c2)N=C(C2COc4ccc(C(=O)NCCc5cnc[nH]5)cc4C2)C3)n1
InChIInChI=1S/C28H29N5O2.C27H25N7O2.C27H27N5O2.C26H25N5O2.C26H27N5O2.C25H23N5O2/c29-28-30-11-10-23(33-28)17-6-7-18-15-25(32-24(18)14-17)21-13-20-12-19(8-9-26(20)35-16-21)27(34)31-22-4-2-1-3-5-22;28-27-31-8-6-22(34-27)16-1-2-17-12-24(33-23(17)11-16)20-10-19-9-18(3-4-25(19)36-14-20)26(35)30-7-5-21-13-29-15-32-21;28-27-29-10-9-22(32-27)16-5-6-17-14-24(31-23(17)13-16)20-12-19-11-18(7-8-25(19)34-15-20)26(33)30-21-3-1-2-4-21;27-26-28-9-8-21(31-26)15-4-5-16-13-23(30-22(16)12-15)19-11-18-10-17(6-7-24(18)33-14-19)25(32)29-20-2-1-3-20;1-15(2)13-29-25(32)18-5-6-24-19(9-18)10-20(14-33-24)23-12-17-4-3-16(11-22(17)30-23)21-7-8-28-26(27)31-21;1-2-8-27-24(31)17-5-6-23-18(10-17)11-19(14-32-23)22-13-16-4-3-15(12-21(16)29-22)20-7-9-28-25(26)30-20/h6-12,14,21-22H,1-5,13,15-16H2,(H,31,34)(H2,29,30,33);1-4,6,8-9,11,13,15,20H,5,7,10,12,14H2,(H,29,32)(H,30,35)(H2,28,31,34);5-11,13,20-21H,1-4,12,14-15H2,(H,30,33)(H2,28,29,32);4-10,12,19-20H,1-3,11,13-14H2,(H,29,32)(H2,27,28,31);3-9,11,15,20H,10,12-14H2,1-2H3,(H,29,32)(H2,27,28,31);2-7,9-10,12,19H,1,8,11,13-14H2,(H,27,31)(H2,26,28,30)
InChIKeyRELBKLNXMFWLTJ-UHFFFAOYSA-N
MW2707.21 g/mol
LogP23.65
Rot. Bonds28

About 3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclobutyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclohexyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclopentyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-(2-methylpropyl)-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-prop-2-enyl-3,4-dihydro-2H-chromene-6-carboxamide

3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclobutyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclohexyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclopentyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-(2-methylpropyl)-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-prop-2-enyl-3,4-dihydro-2H-chromene-6-carboxamide (PubChem CID 160602306) has the molecular formula C159H156N32O12 and a molecular weight of 2707.21 g/mol. Its IUPAC name is 3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclobutyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclohexyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclopentyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-(2-methylpropyl)-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-prop-2-enyl-3,4-dihydro-2H-chromene-6-carboxamide.

Molecular Properties

Compound Name3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclobutyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclohexyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclopentyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-(2-methylpropyl)-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-prop-2-enyl-3,4-dihydro-2H-chromene-6-carboxamide
PubChem CID160602306
Molecular FormulaC159H156N32O12
Molecular Weight2707.21 g/mol
Exact Mass2705.26
IUPAC Name3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclobutyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclohexyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclopentyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-(2-methylpropyl)-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-prop-2-enyl-3,4-dihydro-2H-chromene-6-carboxamide
SMILESC=CCNC(=O)c1ccc2c(c1)CC(C1=Nc3cc(-c4ccnc(N)n4)ccc3C1)CO2.CC(C)CNC(=O)c1ccc2c(c1)CC(C1=Nc3cc(-c4ccnc(N)n4)ccc3C1)CO2.Nc1nccc(-c2ccc3c(c2)N=C(C2COc4ccc(C(=O)NC5CCC5)cc4C2)C3)n1.Nc1nccc(-c2ccc3c(c2)N=C(C2COc4ccc(C(=O)NC5CCCC5)cc4C2)C3)n1.Nc1nccc(-c2ccc3c(c2)N=C(C2COc4ccc(C(=O)NC5CCCCC5)cc4C2)C3)n1.Nc1nccc(-c2ccc3c(c2)N=C(C2COc4ccc(C(=O)NCCc5cnc[nH]5)cc4C2)C3)n1
InChIInChI=1S/C28H29N5O2.C27H25N7O2.C27H27N5O2.C26H25N5O2.C26H27N5O2.C25H23N5O2/c29-28-30-11-10-23(33-28)17-6-7-18-15-25(32-24(18)14-17)21-13-20-12-19(8-9-26(20)35-16-21)27(34)31-22-4-2-1-3-5-22;28-27-31-8-6-22(34-27)16-1-2-17-12-24(33-23(17)11-16)20-10-19-9-18(3-4-25(19)36-14-20)26(35)30-7-5-21-13-29-15-32-21;28-27-29-10-9-22(32-27)16-5-6-17-14-24(31-23(17)13-16)20-12-19-11-18(7-8-25(19)34-15-20)26(33)30-21-3-1-2-4-21;27-26-28-9-8-21(31-26)15-4-5-16-13-23(30-22(16)12-15)19-11-18-10-17(6-7-24(18)33-14-19)25(32)29-20-2-1-3-20;1-15(2)13-29-25(32)18-5-6-24-19(9-18)10-20(14-33-24)23-12-17-4-3-16(11-22(17)30-23)21-7-8-28-26(27)31-21;1-2-8-27-24(31)17-5-6-23-18(10-17)11-19(14-32-23)22-13-16-4-3-15(12-21(16)29-22)20-7-9-28-25(26)30-20/h6-12,14,21-22H,1-5,13,15-16H2,(H,31,34)(H2,29,30,33);1-4,6,8-9,11,13,15,20H,5,7,10,12,14H2,(H,29,32)(H,30,35)(H2,28,31,34);5-11,13,20-21H,1-4,12,14-15H2,(H,30,33)(H2,28,29,32);4-10,12,19-20H,1-3,11,13-14H2,(H,29,32)(H2,27,28,31);3-9,11,15,20H,10,12-14H2,1-2H3,(H,29,32)(H2,27,28,31);2-7,9-10,12,19H,1,8,11,13-14H2,(H,27,31)(H2,26,28,30)
InChIKeyRELBKLNXMFWLTJ-UHFFFAOYSA-N
XLogP23.65
TPSA643.62 Ų
H-Bond Donors13
H-Bond Acceptors37
Rotatable Bonds28
Heavy Atoms203
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002707.21
LogP ≤ 523.65
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1037

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclobutyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclohexyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclopentyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-(2-methylpropyl)-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-prop-2-enyl-3,4-dihydro-2H-chromene-6-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-(6-(2-aminopyrimidin-4-yl)-1H-benzo[d]imidazol-2-yl)-N-benzylchroman-6-carboxamide
CID 44563191
3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-N-(pyridin-3-ylmethyl)-3,4-dihydro-2H-chromene-6-carboxamide
CID 46881514
3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-N-(2-pyridin-2-ylethyl)-3,4-dihydro-2H-chromene-6-carboxamide
CID 46881516
3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-N-(2-pyridin-3-ylethyl)-3,4-dihydro-2H-chromene-6-carboxamide
CID 46881563
3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-N-cyclohexyl-3,4-dihydro-2H-chromene-6-carboxamide
CID 46845957
3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-N-(2-phenylethyl)-3,4-dihydro-2H-chromene-6-carboxamide
CID 46881515
3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-N-[2-(4-methoxyphenyl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide
CID 67062489
3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-N-(2-phenylpropyl)-3,4-dihydro-2H-chromene-6-carboxamide
CID 67062500
3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-N-methyl-N-(2-phenylethyl)-3,4-dihydro-2H-chromene-6-carboxamide
CID 67062527
3-[6-(2-aminopyrimidin-4-yl)-1H-benzimidazol-2-yl]-N-[2-(2-methoxyphenyl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide
CID 67062596
3-[6-(2-aminopyrimidin-4-yl)-4-fluoro-3H-indol-2-yl]-N-[2-(4-methoxyphenyl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide
CID 58164110
1-(1-benzofuran-5-carbonyl)-N-(4-methylphenyl)piperidine-3-carboxamide;5,5-difluoro-1-[3-(1H-imidazol-2-yl)benzoyl]-N-(4-methylphenyl)piperidine-3-carboxamide;5,5-difluoro-N-(4-methylphenyl)-1-(3-pyridin-2-ylbenzoyl)piperidine-3-carboxamide;5,5-difluoro-N-(4-methylphenyl)-1-(3-pyridin-3-ylbenzoyl)piperidine-3-carboxamide;5,5-difluoro-N-(4-methylphenyl)-1-(3-pyrimidin-5-ylbenzoyl)piperidine-3-carboxamide;N-(2,6-difluorophenyl)-1-[3-(furan-2-yl)benzoyl]piperidine-3-carboxamide;1-[3-(furan-2-yl)benzoyl]-N-(4-methylphenyl)piperidine-3-carboxamide
CID 157568883

Frequently Asked Questions

What is the IUPAC name of 3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclobutyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclohexyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclopentyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-(2-methylpropyl)-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-prop-2-enyl-3,4-dihydro-2H-chromene-6-carboxamide?
The IUPAC name of 3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclobutyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclohexyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclopentyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-(2-methylpropyl)-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-prop-2-enyl-3,4-dihydro-2H-chromene-6-carboxamide (CID 160602306) is 3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclobutyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclohexyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclopentyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-(2-methylpropyl)-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-prop-2-enyl-3,4-dihydro-2H-chromene-6-carboxamide.
What is the SMILES notation for 3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclobutyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclohexyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclopentyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-(2-methylpropyl)-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-prop-2-enyl-3,4-dihydro-2H-chromene-6-carboxamide?
The canonical SMILES for 3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclobutyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclohexyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclopentyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-(2-methylpropyl)-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-prop-2-enyl-3,4-dihydro-2H-chromene-6-carboxamide is C=CCNC(=O)c1ccc2c(c1)CC(C1=Nc3cc(-c4ccnc(N)n4)ccc3C1)CO2.CC(C)CNC(=O)c1ccc2c(c1)CC(C1=Nc3cc(-c4ccnc(N)n4)ccc3C1)CO2.Nc1nccc(-c2ccc3c(c2)N=C(C2COc4ccc(C(=O)NC5CCC5)cc4C2)C3)n1.Nc1nccc(-c2ccc3c(c2)N=C(C2COc4ccc(C(=O)NC5CCCC5)cc4C2)C3)n1.Nc1nccc(-c2ccc3c(c2)N=C(C2COc4ccc(C(=O)NC5CCCCC5)cc4C2)C3)n1.Nc1nccc(-c2ccc3c(c2)N=C(C2COc4ccc(C(=O)NCCc5cnc[nH]5)cc4C2)C3)n1.
What is the InChIKey of 3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclobutyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclohexyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclopentyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-(2-methylpropyl)-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-prop-2-enyl-3,4-dihydro-2H-chromene-6-carboxamide?
The InChIKey is RELBKLNXMFWLTJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H29N5O2.C27H25N7O2.C27H27N5O2.C26H25N5O2.C26H27N5O2.C25H23N5O2/c29-28-30-11-10-23(33-28)17-6-7-18-15-25(32-24(18)14-17)21-13-20-12-19(8-9-26(20)35-16-21)27(34)31-22-4-2-1-3-5-22;28-27-31-8-6-22(34-27)16-1-2-17-12-24(33-23(17)11-16)20-10-19-9-18(3-4-25(19)36-14-20)26(35)30-7-5-21-13-29-15-32-21;28-27-29-10-9-22(32-27)16-5-6-17-14-24(31-23(17)13-16)20-12-19-11-18(7-8-25(19)34-15-20)26(33)30-21-3-1-2-4-21;27-26-28-9-8-21(31-26)15-4-5-16-13-23(30-22(16)12-15)19-11-18-10-17(6-7-24(18)33-14-19)25(32)29-20-2-1-3-20;1-15(2)13-29-25(32)18-5-6-24-19(9-18)10-20(14-33-24)23-12-17-4-3-16(11-22(17)30-23)21-7-8-28-26(27)31-21;1-2-8-27-24(31)17-5-6-23-18(10-17)11-19(14-32-23)22-13-16-4-3-15(12-21(16)29-22)20-7-9-28-25(26)30-20/h6-12,14,21-22H,1-5,13,15-16H2,(H,31,34)(H2,29,30,33);1-4,6,8-9,11,13,15,20H,5,7,10,12,14H2,(H,29,32)(H,30,35)(H2,28,31,34);5-11,13,20-21H,1-4,12,14-15H2,(H,30,33)(H2,28,29,32);4-10,12,19-20H,1-3,11,13-14H2,(H,29,32)(H2,27,28,31);3-9,11,15,20H,10,12-14H2,1-2H3,(H,29,32)(H2,27,28,31);2-7,9-10,12,19H,1,8,11,13-14H2,(H,27,31)(H2,26,28,30).
What are the key properties of 3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclobutyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclohexyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclopentyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-(2-methylpropyl)-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-prop-2-enyl-3,4-dihydro-2H-chromene-6-carboxamide?
3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclobutyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclohexyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclopentyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-(2-methylpropyl)-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-prop-2-enyl-3,4-dihydro-2H-chromene-6-carboxamide has a molecular weight of 2707.21 g/mol, XLogP of 23.65, 28 rotatable bonds, 13 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclobutyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclohexyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-cyclopentyl-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-[2-(1H-imidazol-5-yl)ethyl]-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-(2-methylpropyl)-3,4-dihydro-2H-chromene-6-carboxamide;3-[6-(2-aminopyrimidin-4-yl)-3H-indol-2-yl]-N-prop-2-enyl-3,4-dihydro-2H-chromene-6-carboxamide is sourced from PubChem (CID 160602306), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).